Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Many peptide researchers are interested in conducting ipamorelin studies
This is how studies produce confounding, unrepeatable results
One thing that can provide relief
Meta-analyses suggest a small but statistically significant effect on body weight, with average reductions of 1-2 kg over 12 weeks
A: According to clinical trial data and real-world reports: Initial weight loss (2-5 pounds): Often within first 2-4 weeks Noticeable changes (5-10% body weight): Typically 3-6 months Maximum results (15-20% body weight): Usually 12-18 months Weight loss is gradual and occurs throughout dose escalation and maintenance phases
SURMOUNT-5, the first head-to-head trial (published in NEJM, 2025), found tirzepatide produced about 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks
